Literature DB >> 3518423

Subclavian hemodialysis catheter infections.

P J Dahlberg, W R Yutuc, K L Newcomer.   

Abstract

One hundred sixteen subclavian hemodialysis catheter placements in 88 patients were prospectively evaluated for catheter-related infections. Semiquantitative culture techniques and a rigid infection control protocol were used. The overall catheter colonization rate was 21.6% and catheter-associated bacteremia occurred in 9.4%. Catheters removed from febrile patients had much higher colonization (48.3%) and bacteremia (34.5%) rates. In a randomized study comparing infection rates in catheters tunneled subcutaneously or not tunneled, there was no significant difference in the incidence of infection. Catheters inserted over a guidewire to replace clotted or malfunctioning catheters were not associated with higher infection rates.

Entities:  

Mesh:

Year:  1986        PMID: 3518423     DOI: 10.1016/s0272-6386(86)80092-0

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

1.  Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice.

Authors:  R J Sherertz; D M Forman; D D Solomon
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 2.  Interventions for treating catheter-related bloodstream infections in people receiving maintenance haemodialysis.

Authors:  Beatriz M Almeida; Daniel H Moreno; Vladimir Vasconcelos; Daniel G Cacione
Journal:  Cochrane Database Syst Rev       Date:  2022-04-01

Review 3.  Interventions for treating central venous haemodialysis catheter malfunction.

Authors:  Alice L Kennard; Giles D Walters; Simon H Jiang; Girish S Talaulikar
Journal:  Cochrane Database Syst Rev       Date:  2017-10-26

4.  Bacteremia in a pediatric hemodialysis unit secondary to Enterococcus fecalis.

Authors:  L C Hymes; B L Warshaw; B Clowers; P Newsome; H L Keyserling
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.